News

OmniComm will build and host the study for GLPI by installing TrialMaster for electronic data capture. With the eLearning system, OmniComm will train more than 60 site users

The move follows the company’s rising debt burdens, which has amounted to a total of Rs15bn ($290m). The company said that the Jammu plant is still under trial

Neutra is recruiting volunteers to test the effectiveness of its new, enriched formula and is expected to start the trials shortly. The trials aim at distinguishing Pure Plus

Cuba’s Ministry of Information and Communications and China’s Inspur Electronic Information Industry said they wanted to develop bilateral trade, reports Indo-Asian News Service. Shandong deputy governor Cai Limin

The purchase is expected to allow the company to focus on manufacturing anthelmintics, such as Albendazol EP, Albendazole IP/USP, Cyromazine, Fenbendazole, BP VET / EP, Nitroxynil BP Vet,

Under the agreement, Nuron is responsible for development and commercialization of the vaccine. Financial terms of the agreement have not been disclosed. The DNA vaccine, which contains a

The proposed transaction could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation. PharmaLife is also expected to make safe, timely product registration within

As per the agreement, AnaptysBio will use its SHM-XEL platform to produce therapeutic antibodies to oncology and inflammation-related targets. Celgene will gain worldwide rights to develop and commercialize

VitaMedMD One Rx is a single daily dose softgel containing 14 vitamins, minerals, and 200mg of plant-based docosahexaenoic acid. The prenatal vitamin supplement contains the same combination of